Midgard
Byondis

Byondis

Nijmegen, Netherlands byondis.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Byondis is a biopharmaceutical company focused on developing proprietary cancer medicines, especially antibody-drug conjugates and other targeted modalities. It conducts in-house research, development, and GMP manufacturing for its own pipeline and works from Nijmegen, The Netherlands.

Services

  • Research and development

    In-house drug discovery and development for targeted medicines based on new biological and chemical entities, with biomarker and combination strategy work.

  • ADC platform development

    Development of antibody-drug conjugate platforms including antifolate ADCs, masked therapeutics, phosphonate ADCs, and duocarmazine-based technologies.

  • Protein engineering and conjugation technologies

    Protein modification services including site-specific conjugation, antibody conjugation, and dual-linker or branched-linker technologies.

  • Cell line development and cell culture

    Cell line development and cell culture capabilities supporting biologics research and manufacturing.

  • Protein purification and formulation

    Protein purification, analytics, and formulation work for biologics and conjugates.

  • GMP manufacturing

    In-house GMP manufacturing and conjugation facilities for mAbs and ADCs up to early commercial launch scale.

  • ADC material and IMP release

    Manufacturing and release of ADC material and investigational medicinal product for clinical programs.

  • Antifolate ADC platform

    Develops an antifolate linker-drug platform intended to overcome ADC resistance and systemic side effects in oncology programs.

6 more services
  • Masked therapeutics platform
  • Phosphonate ADC platform
  • Integrated R&D
  • Manufacturing
  • Protein purification and modification
  • Small-molecule chemistry

Capabilities

Assays and studies
  • ADCs
  • Antibodies
  • Process development
  • Small molecules
  • In vitro efficacy
  • In vivo efficacy
3 more
  • PK/PD studies
  • Safety studies
  • Biomarker identification
Scale and capacity
  • Dual 2,000L bioreactors
  • 73,000 square meters
  • 2,000 m2 of laboratory space
  • 2,400 m2 office space
  • 800 m2 GMP warehouse
  • About 200 employees
Therapeutic areas
  • Oncology
  • Immunology

Instruments and platforms

  • Single-use bioreactors

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
Species and models
Various tumor models

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: GMP (Manufacturing and conjugation facilities)

Industries served

  • Oncology

Details

Type
CRDMO
Founded
2007
Team
About 200 highly qualified employees
Address
Microweg 22 6545 CM Nijmegen, The Netherlands VAT number: NL8511.30.975
Phone
+31 (0)24 679 5100

Similar labs